2014
DOI: 10.1182/blood-2013-07-517938
|View full text |Cite
|
Sign up to set email alerts
|

Leukocyte cell-derived chemotaxin 2 (LECT2)–associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States

Abstract: Key Points Leukocyte cell-derived chemotaxin-2–associated amyloidosis (ALect2) is a common cause of systemic amyloidosis involving the liver. Recognition and accurate diagnosis of hepatic ALect2 amyloidosis is essential for accurate management of patients with hepatic amyloidosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
86
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 73 publications
(90 citation statements)
references
References 24 publications
3
86
0
1
Order By: Relevance
“…In sharp contrast to other types of systemic amyloidosis, ALECT2 amyloidosis exhibits a strong ethnic bias, with 88%-92% of reported patients being Hispanics (5,11,12). All reported Hispanic patients who disclosed their origin were of Mexican descent (12,16).…”
Section: Introductionmentioning
confidence: 99%
See 4 more Smart Citations
“…In sharp contrast to other types of systemic amyloidosis, ALECT2 amyloidosis exhibits a strong ethnic bias, with 88%-92% of reported patients being Hispanics (5,11,12). All reported Hispanic patients who disclosed their origin were of Mexican descent (12,16).…”
Section: Introductionmentioning
confidence: 99%
“…Of 120 patients with ALECT2 amyloidosis diagnosed by liquid chromatography/mass spectrometry (LC/MS) at the Mayo Clinic between 2007 and 2012, 72 affected the kidney, 36 liver, five spleen, three prostate, and one each from gallbladder, pancreas, small bowel, and parathyroid gland (12). Interestingly, most patients with ALECT2 amyloidosis reported so far were diagnosed by kidney biopsy in patients without clinically evident extrarenal organ involvement (5,12,17) or liver biopsy in patients without clinically evident extrahepatic organ involvement (11). A patient with biopsy-proven pulmonary ALECT2 amyloidosis was also reported (21).…”
Section: Affected Organsmentioning
confidence: 99%
See 3 more Smart Citations